“Real-World Effectiveness of Upadacitinib in Moderate‑to‑Severe Atopic Dermatitis (AD): Results From Longitudinal Analyses of the CorEvitas AD Registry”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s450, https://doi.org/10.25251/skin.8.supp.450.